Cargando…

Policy Disparities in Response to COVID-19 between China and South Korea

Objectives: This study analyzed the effects of COVID-19 non-pharmaceutical measures between China and South Korea to share experiences with other countries in the struggle against SARS-CoV-2. Methods: We used the generalized linear model to examine the associations between non-pharmaceutical measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haiqian, Shi, Leiyu, Zhang, Yuyao, Wang, Xiaohan, Sun, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242108/
https://www.ncbi.nlm.nih.gov/pubmed/33876595
http://dx.doi.org/10.2991/jegh.k.210322.001
_version_ 1783715559398965248
author Chen, Haiqian
Shi, Leiyu
Zhang, Yuyao
Wang, Xiaohan
Sun, Gang
author_facet Chen, Haiqian
Shi, Leiyu
Zhang, Yuyao
Wang, Xiaohan
Sun, Gang
author_sort Chen, Haiqian
collection PubMed
description Objectives: This study analyzed the effects of COVID-19 non-pharmaceutical measures between China and South Korea to share experiences with other countries in the struggle against SARS-CoV-2. Methods: We used the generalized linear model to examine the associations between non-pharmaceutical measures adopted by China and South Korea and the number of confirmed cases. Policy disparities were also discussed between these two countries. Results: The results show that the following factors influence the number of confirmed cases in China: lockdown of Wuhan city (LWC); establishment of a Leading Group by the Central Government; raising the public health emergency response to the highest level in all localities; classifying management of “four categories of personnel”; makeshift hospitals in operation (MHIO); pairing assistance (PA); launching massive community screening (LMCS). In South Korea, these following factors were the key influencing factors of the cumulative confirmed cases: raising the public alert level to orange (three out of four levels); raising the public alert to the highest level; launching drive-through screening centers (LDSC); screening all members of Shincheonji religious group; launching Community Treatment Center (LCTC); distributing public face masks nationwide and quarantining all travelers from overseas countries for 14 days. Conclusion: Based on the analysis of the generalized linear model, we found that a series of non-pharmaceutical measures were associated with contain of the COVID-19 outbreak in China and South Korea. The following measures were crucial for both of them to fight against the COVID-19 epidemic: a strong national response system, expanding diagnostic tests, establishing makeshift hospitals, and quarantine or lockdown affected areas.
format Online
Article
Text
id pubmed-8242108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Atlantis Press
record_format MEDLINE/PubMed
spelling pubmed-82421082021-07-13 Policy Disparities in Response to COVID-19 between China and South Korea Chen, Haiqian Shi, Leiyu Zhang, Yuyao Wang, Xiaohan Sun, Gang J Epidemiol Glob Health Research Article Objectives: This study analyzed the effects of COVID-19 non-pharmaceutical measures between China and South Korea to share experiences with other countries in the struggle against SARS-CoV-2. Methods: We used the generalized linear model to examine the associations between non-pharmaceutical measures adopted by China and South Korea and the number of confirmed cases. Policy disparities were also discussed between these two countries. Results: The results show that the following factors influence the number of confirmed cases in China: lockdown of Wuhan city (LWC); establishment of a Leading Group by the Central Government; raising the public health emergency response to the highest level in all localities; classifying management of “four categories of personnel”; makeshift hospitals in operation (MHIO); pairing assistance (PA); launching massive community screening (LMCS). In South Korea, these following factors were the key influencing factors of the cumulative confirmed cases: raising the public alert level to orange (three out of four levels); raising the public alert to the highest level; launching drive-through screening centers (LDSC); screening all members of Shincheonji religious group; launching Community Treatment Center (LCTC); distributing public face masks nationwide and quarantining all travelers from overseas countries for 14 days. Conclusion: Based on the analysis of the generalized linear model, we found that a series of non-pharmaceutical measures were associated with contain of the COVID-19 outbreak in China and South Korea. The following measures were crucial for both of them to fight against the COVID-19 epidemic: a strong national response system, expanding diagnostic tests, establishing makeshift hospitals, and quarantine or lockdown affected areas. Atlantis Press 2021-06 /pmc/articles/PMC8242108/ /pubmed/33876595 http://dx.doi.org/10.2991/jegh.k.210322.001 Text en © 2021 The Authors. Published by Atlantis Press International B.V. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ).
spellingShingle Research Article
Chen, Haiqian
Shi, Leiyu
Zhang, Yuyao
Wang, Xiaohan
Sun, Gang
Policy Disparities in Response to COVID-19 between China and South Korea
title Policy Disparities in Response to COVID-19 between China and South Korea
title_full Policy Disparities in Response to COVID-19 between China and South Korea
title_fullStr Policy Disparities in Response to COVID-19 between China and South Korea
title_full_unstemmed Policy Disparities in Response to COVID-19 between China and South Korea
title_short Policy Disparities in Response to COVID-19 between China and South Korea
title_sort policy disparities in response to covid-19 between china and south korea
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242108/
https://www.ncbi.nlm.nih.gov/pubmed/33876595
http://dx.doi.org/10.2991/jegh.k.210322.001
work_keys_str_mv AT chenhaiqian policydisparitiesinresponsetocovid19betweenchinaandsouthkorea
AT shileiyu policydisparitiesinresponsetocovid19betweenchinaandsouthkorea
AT zhangyuyao policydisparitiesinresponsetocovid19betweenchinaandsouthkorea
AT wangxiaohan policydisparitiesinresponsetocovid19betweenchinaandsouthkorea
AT sungang policydisparitiesinresponsetocovid19betweenchinaandsouthkorea